The use of antimony compounds, particularly potassium antimonyl tartrate (Tartar emetic), in Cryptococcosis has occasionally been mentioned in the literature,2"' but no experimental study of the therapeutic rationale of the use of antimonials in this infection has to our knowledge ever been undertaken. It did not seem that Tartar emetic was of any therapeutic value, but this should not reflect on the chemotherapeutic possibilities of the entire class of antimony derivatives. In rather extensive investigations on the therapeutic sensitivity of the chronic infection of mice with C. neoformans carried out in this laboratory it was observed that certain antimonials do indeed possess a marked effect in this otherwise resistant infection.
The active antimonials belong to the group of carbamylbenzene stibonic acids, synthesized by Dr 
H203Sbf>CONHC2H4NHC2H40H
(I) The compound contains approximately 31 'o Sb and was used in the form of its water soluble diethanolamine salt.
MATERIALS AND METHODS
Strain of C. neoformans. This strain was received through the courtesy of Dr. M.
Tager, Emory University, Atlanta, Georgia in 1947 and has been kept on glucose Sabouraud agar slants ever since. Transfers were made as a rule every 2d or 3d day. For the infection of mice 48-hour cultures in Sabouraud's broth were employed.
EXPERIMENTAL PROCEDURE
Mice of 18-22 g. from one colony were used in these experiments. The animals were infected intra-abdominally with 0.5 ml. of a 48-hours C. neoformans broth culture corresponding to 1,000,000 to 2,000,000 viable organ-isms according to plate counts. This infection was fatal for an average of 80%fo of the animals within three weeks, with the majority of the animals dying between the 10th and 14th day. The infected mice were divided into groups of 10 to 20 animals. The treatment, always by the subcutaneous route, was started within 5-10 minutes after the infection. In most experiments one daily dose was given for 21 days. All animals that died at least five days after the infection were autopsied, the organs were examined, and cultures on Sabouraud agar taken which were read after 48 hours' incubation. On the 22d day all surviving animals were sacrificed, examined, and cultured in the same way. The pathological lesions produced by the infection used were most marked in the lungs. Liver and spleen showed little or no gross involvement. The lungs showed a high degree of pathological change in the form of numerous whitish nodules which tended to become confluent. Therefore, the criteria on which evaluation of Ro 2-3094 and other comparative compounds was based were the gross lesions of the lungs and the cultures derived from this organ. In several instances cultures were also taken from the brain. Since the results of the brain cultures were almost identical with those of the lungs, brain cultures were not taken regularly.
The extent of gross lung lesions and of the growth on agar slants was estimated using the symbols 1 + to 3 +. In this type of grading 3 + indicated widespread lesions in all pulmonary lobes and-in cultures-the complete covering of the agar surface with confluent growth; 2 + and + signify lower degrees of involvement and lighter growth of cultures. In cases where very few and small lesions and not more than 20 colonies were seen, actual counts were made and, for the purpose of averaging, designated as 0.5 + or less. Absence of the lesions and growth on agar was marked as zero. The average of the lesions and cultures was calculated from the sum of the plus and minus symbols. This evaluation was supplemented by the ratio c/t of average of lesions in controls: average of lesions in treated animals, and the same ratio was calculated from the results of the cultures. Inactive compounds had a ratio close to 1.0. Activity was characterized by values of more than 2.0.
EXPERIMENTAL TOXICITY OF RO 2-3094
The acute toxicity was determined by single injection into mice using the subcutaneous and intravenous routes and in rabbits by intramuscular or intravenous injection. The observation time was at least three days. The results as given in Table 1 indicate that the compound showed the comparatively low toxicity characteristic for stibonic acids.
Repeated daily drug administration of 50, 100, and 250 mg./kg. was well tolerated by the majority of mice for periods up to three weeks. Rabbits tolerated 10 intramuscular injections of 20 mg./kg. given alternately into the right and left hind leg without symptoms of systemic toxic effects. However, the animals showed at autopsy the characteristic tissue necrosis which almost invariably follows the injection of antimonials. These compounds, as well as Ro 2-3094, were given at a dose of approximately one-fifth of the tolerated dose as found at single administration.
The results as given in Table 2 show that only Ro 2-3094 exerted a marked effect in the C. neoformans infection. This is shown by the high survival rate and by the appreciable reduction in the extent of lung lesions and of organisms recovered by culture as compared to controls and unsuccessfully treated mice. As a rule 50%o or more of the animals were free of lesions and gave negative cultures. This effect appeared to be independent of the Sb content, if one compares the three stibonic acids which were given in comparable doses. The tervalent antimonials cannot be used for such a comparison.
It might also be mentioned that 15 additional antimonials, most of them stibonic acids, have been tested, but only one of them, closely related to Ro 2-3094, showed activity against C. neoformans and this in lesser degree.
The experiments with Ro 2-3094 have been repeated on different occasions, altogether 16 times, and the same results were obtained with negligible variations. A survey of these experiments is given in Table 3 .
The animals listed in this table also contain a group of 40 treated and 27 untreated mice in which cultures were taken from the brain. The results were very similar to those obtained with the lungs. The average extent of growth of the brain cultures from the untreated controls was 1.6, the corresponding value from the brain of the treated mice, 0.6. This gave a ratio c/t of 2.7. That this value is lower than that obtained in the evaluation of the lungs is due to the fact that average strength of the brain cultures was as a rule lower than that of the lungs. In an additional series of experiments we tried to increase the protective effect of Ro 2-3094 by increasing the dose of the drug. At the same time we attempted to reduce the frequency of administration by giving higher doses, e.g. the tolerated dose, of the drug. The results of this experiment in which four different dosage schedules were used are compiled in Table 4 . It will be seen from this table that all four dosage schedules, covering total doses of 5.2 to 1.05 g./kg., exerted the expected effect on the survival rate which varied from 60%o to 80%o, while all untreated controls died. Slight, statistically insignificant differences were observed in the extent of lesions. The reduction of culture growth was significantly greater in group A (total dose 5.2 g./kg.) than in the remaining groups treated with the lower doses of 2.1, 1.5, and 1.05 g./kg. The "P" values were less than 0.02 for the difference between groups A and B and less than 0.01 for the differences between A and C and A and D. This seemed to indicate that at least the influence of the drug on the recovery of the organisms from the lungs was dependent on the dose within the range of dosages tested.
In one experiment in which the observation time was extended another three weeks after discontinuance of therapy (50 mg./kg. for 21 days) delayed death occurred in the group of treated mice. Nine out of 10 mice lived 27 days post-infection; seven of the mice died between the 30th and 40th day. Autopsy showed, however, that the extent of lung lesions and the growth on agar had not increased as demonstrated by the average values of 0.6 for lesions and 1.0 for cultures. The corresponding figures for the controls which had died within the first three weeks after the infections were 2.3 and 2.8, respectively. At present this observation cannot be fully discussed because we have not done Ro 2-3094 chronic toxicity experiments on non-infected mice. Practically identical findings can be found in one of the experiments with Fungicidin as reported by Hazen and Brown.' Ro 2-3094 has not been tested so far in other fungus infections. The only other chemotherapeutic property we found was a slight trypanocidal activity in T. brucei infections which could, however, only be observed with the dose of 500 mg./kg. which was toxic for half of the treated animals.
DISCUSSION
From the data of the experimental part, we have concluded that the stibonic acid Ro 2-3094 under the conditions of the test exerts a marked effect on survival time, pathology, and cultural recovery of the causative agent in infections of mice with the strain of C. neoformans used in these experiments. Only one closely related stibonic acid had a similar although less consistent activity, while 18 additional organic antimonials and a great number of synthetic compounds from different chemical classes failed to show an influence in this infection. Ro 2-3094 seems, as far as can be learned from the literature, the only synthetic product able to control the C. neoformans infection, although sulfadiazine has been mentioned by Reilly and Artman' as prolonging life in infected rats. Antibiotics of microbial origin seemed more frequently to be efficacious in this fungus infection. Streptomycin1'6 and penicillin' had some activity in experimental infections, while Actidione,." Polymyxin B,8 and other antibiotics5 were without effect in mice, although some of them, e.g. Actidione and Polymyxin B, may be potentially useful in central nervous system cryptococcosis of humans. High in vivo activity in cryptococcal infections is apparently limited to Fungicidin. Effects very similar to those observed with Ro 2-3094 and with occasionally longer lasting success were observed by Hazen and Brown.' SUMMARY The stibonic acid Ro 2-3094, a member of the group of substituted carbamylbenzene stibonic acids, exerted a protective chemotherapeutic effect in experimental infections of mice with C. neoformans and seems to be the first synthetic compound to show a definite effect in this infection.
